Alambic Investment Management’s Psychemedics Corporation PMD Stock Holding History

Alambic Investment Management’s Portfolio PMD Stock Details PMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-11,636	Closed	-$163K	–	393
2019 Q1	$163K	Buy	+11,636	New	+$200K	0.07%	299
2018 Q3	–	Sell	-11,751	Closed	-$226K	–	379
2018 Q2	$226K	Sell	11,751 -1,430	-11%	-$29K	0.06%	300
2018 Q1	$282K	Sell	13,181 -889	-6%	-$18.5K	0.04%	378
2017 Q4	$289K	Sell	14,070 -8,457	-38%	-$157K	0.03%	376
2017 Q3	$415K	Sell	22,527 -8,300	-27%	-$183K	0.05%	373
2017 Q2	$769K	Buy	30,827 +1,033	+3%	+$21.7K	0.09%	308
2017 Q1	$597K	Buy	29,794 +17,968	+152%	+$394K	0.07%	377
2016 Q4	$292K	Buy	+11,826	New	+$265K	0.05%	430

Other funds holding PMD

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

CIC

Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Alambic Investment Management's PMD Position: Q2 2019 in Review

Alambic Investment Management sold out of Psychemedics Corporation (PMD) in Q2 2019, closing a stake of 11,636 shares — an estimated $163K sold.

Alambic Investment Management first reported a position in PMD in Q4 2016 and held it in 8 quarters. The position peaked at $769K in Q2 2017. 46 funds tracked by Wall St. Rank hold PMD as of Q2 2019.

Alambic Investment Management reported no remaining Psychemedics Corporation position as of Q2 2019 after selling out during the quarter.
Alambic Investment Management sold 11,636 Psychemedics Corporation shares in Q2 2019, an estimated $163K.
Alambic Investment Management first reported a position in Psychemedics Corporation in Q4 2016 and held it in 8 quarters.
Alambic Investment Management's Psychemedics Corporation position peaked at $769K in Q2 2017.
46 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q2 2019.

Based on Alambic Investment Management's 13F filing for Q2 2019, filed 13 Aug 2019.